Neuren Pharmaceuticals Receives US$10m milestone payment
Neuren Pharmaceuticals (NEU) receives a US$10 million (A$16 million) milestone payment from its partner, Acadia Pharmaceuticals
The payment...
Neuren Pharmaceuticals Receives priority review for trofinetide NDA
Neuren Pharmaceuticals (NEU) receives priority review for a New Drug Application (NDA) of its trofinetide drug...
